What is the global market size of Coronary Stent Market?

Coronary Stent Market size was valued at USD 8.8 Billion in 2021 and is poised to grow from USD 9.09 Billion in 2022 to USD 11.79 Billion by 2030, at a CAGR of 3.3% during the forecast period (2023-2030).

Top Coronary Stent Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Coronary Stent Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Coronary Stent industry players.

Coronary Stent Market Competitive Landscape

Additionally, they invest heavily in clinical trials and regulatory approvals to ensure the safety and efficacy of their products. The market also witnesses intense competition in terms of pricing, as players strive to offer cost-effective solutions without compromising on quality. Moreover, companies operating in the global coronary stents market are actively engaged in improving their manufacturing processes to increase production efficiency and meet the growing demand for stents. They also focus on building strong distribution networks and establishing strong relationships with healthcare providers to enhance product accessibility.

Top Players in Coronary Stent Market

Abbott Laboratories (USA)
Medtronic plc (Ireland)
Boston Scientific Corporation (USA)
Biosensors International Group, Ltd. (Singapore)
Biotronik SE & Co. KG (Germany)
B. Braun Melsungen AG (Germany)
Terumo Corporation (Japan)
MicroPort Scientific Corporation (China)
Lepu Medical Technology (Beijing) Co., Ltd. (China)
Sahajanand Medical Technologies Pvt. Ltd. (India)
Meril Life Sciences Pvt. Ltd. (India)
Vascular Concepts (India)
Translumina GmbH (Germany)
Cordis Corporation (USA)
Reva Medical, Inc. (USA)
Elixir Medical Corporation (USA)
Stentys SA (France)
Alvimedica (Turkey)
Balton Medical (Sweden)
Cardionovum (USA)

Coronary Stent Market

Coronary Stent Market Report Snapshots

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Coronary Stent Market size was valued at USD 425.49 Billion in 2023 and is poised to grow from USD 448.47 Billion in 2024 to USD 683.06 Billion by 2032, growing at a CAGR of 5.4% during the forecast period (2025-2032).

The global coronary stents market is highly competitive and characterized by the presence of several key players. These players compete based on factors such as product portfolio, technological advancements, pricing strategies, and market reach. The market is driven by continuous research and development efforts aimed at introducing innovative stent designs, improving drug-eluting capabilities, and enhancing biocompatibility. Market players focus on strategic collaborations, partnerships, and mergers and acquisitions to expand their market presence and gain a competitive edge. 'Abbott Laboratories (USA) ', 'Medtronic plc (Ireland) ', 'Boston Scientific Corporation (USA) ', 'Biosensors International Group, Ltd. (Singapore) ', 'Biotronik SE & Co. KG (Germany) ', 'B. Braun Melsungen AG (Germany) ', 'Terumo Corporation (Japan) ', 'MicroPort Scientific Corporation (China) ', 'Lepu Medical Technology (Beijing) Co., Ltd. (China) ', 'Sahajanand Medical Technologies Pvt. Ltd. (India) ', 'Meril Life Sciences Pvt. Ltd. (India) ', 'Vascular Concepts (India) ', 'Translumina GmbH (Germany) ', 'Cordis Corporation (USA) ', 'Reva Medical, Inc. (USA) ', 'Elixir Medical Corporation (USA) ', 'Stentys SA (France) ', 'Alvimedica (Turkey) ', 'Balton Medical (Sweden) ', 'Cardionovum (USA) '

The rising incidence of cardiovascular diseases, including coronary artery disease, is a major driver for the global coronary stent market. Lifestyle changes, unhealthy diets, and sedentary lifestyles contribute to the growing burden of cardiovascular diseases globally.

Shift towards Minimally Invasive Procedures: There is a growing preference for minimally invasive procedures, including percutaneous coronary intervention (PCI), which drives the demand for coronary stents. Minimally invasive procedures offer benefits such as shorter hospital stays, reduced recovery time, and lower risk of complications compared to traditional open-heart surgeries.

The dominating region in the global coronary stent market is North America, which holds a significant market share. With the presence of renowned casinos in Las Vegas and Atlantic City, North America has established itself as a gambling hub. The region boasts a thriving casino industry and is home to several major players in the gaming equipment market. The demand for cutting-edge gaming machines, electronic gaming tables, and other equipment is consistently high in this region, driving the growth of the market. North America's market share is estimated to be around 40%, making it a key player in the global Coronary Stent market.

Top Coronary Stent Companies

Coronary Stent Market Competitive Landscape

Top Players in Coronary Stent Market

Coronary Stent Market

Coronary Stent Market Report Snapshots

FAQs

What is the global market size of Coronary Stent Market?

Who are the key vendors in the Coronary Stent Market?

What is the key driver of Coronary Stent Market?

What is the key market trend for Coronary Stent Market?

Which region accounted for the largest share in Coronary Stent Market?

Request Free Customization